Mundipharma Pharmaceuticals Ltd
- A01 - Preparados estomatológicos
- BETAISODONA GARGLE mouth wash 1%
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- CONTROLOC gastro-resistant tablet 20 mg
- CONTROLOC gastro-resistant tablet 40 mg
- CONTROLOC IV powder for solution for injection 40 mg
- C05 - Vasoprotectores
- HIRUDOID cream 0.3%
- HIRUDOID gel 0.3%
- D08 - Antisépticos y desinfectantes
- BETAISODONA ALCOHOLIC cutaneous solution 10%
- BETAISODONA ANTISEPTIC PAINT cutaneous solution 10%
- BETAISODONA cream 5%
- BETAISODONA cutaneous spray, powder 2.5%
- BETAISODONA ointment 10%
- BETAISODONA SCALP & SKIN CLEANSER SOLUTION cutaneous solution 7.5%
- BETAISODONA SKIN CLEANSER cutaneous solution 4%
- BETAISODONA STANDARDISED SOLUTION cutaneous solution 10%
- BETAISODONA SURGICAL SCRUB cutaneous solution 7.5%
- G01 - Antiinfecciosos y antisépticos ginecológicos
- BETAISODONA VAGINAL DOUCHE vaginal solution 10%
- BETAISODONA vaginal gel 10%
- BETAISODONA vaginal tablet 200 mg
- L03 - Inmunoestimulantes
- PELMEG PREFILLED SYRINGE solution for injection 6 mg/0.6 ml
- N02 - Analgésicos
- MST CONTINUS prolonged-release tablet 10 mg
- MST CONTINUS prolonged-release tablet 30 mg
- MST CONTINUS prolonged-release tablet 60 mg
- MUNDISAL oromucosal gel 8.71%
- OXYCONTIN prolonged-release tablet 10 mg
- OXYCONTIN prolonged-release tablet 20 mg
- OXYCONTIN prolonged-release tablet 40 mg
- OXYCONTIN prolonged-release tablet 5 mg
- OXYCONTIN prolonged-release tablet 80 mg
- OXYNORM capsule, hard 10 mg
- OXYNORM capsule, hard 20 mg
- OXYNORM capsule, hard 5 mg
- OXYNORM CONCENTRATE oral solution 10 mg/ml
- OXYNORM oral liquid 5 mg/5 ml
- OXYNORM solution for injection 10 mg/1 ml
- OXYNORM solution for injection 20 mg/2 ml
- SEVREDOL film-coated tablet 10 mg
- SEVREDOL film-coated tablet 20 mg
- TARGINACT prolonged-release tablet 10 mg+5 mg
- TARGINACT prolonged-release tablet 20 mg+10 mg
- TARGINACT prolonged-release tablet 40 mg+20 mg
- TARGINACT prolonged-release tablet 5 mg+2.5 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- FLUTIFORM pressurised inhalation, suspension 10 µg/dose+250 µg/dose
- FLUTIFORM pressurised inhalation, suspension 5 µg/dose+125 µg/dose
- FLUTIFORM pressurised inhalation, suspension 5 µg/dose+50 µg/dose
- R05 - Preparados para la tos y el resfriado
- MUCOBROXOL syrup 15 mg/5 ml
- S02 - Otológicos
- AUDAX ear drops, solution 20%